Analyst Report: AMGEN Inc.


Amgen, based in Thousand Oaks, California, is a leading global biotech company. Its key products include Enbrel, Prolia, Otezla, Xgeva, Nplate, Aranesp, Repatha, and Kyprolis. The shares are a component of the S&P 500.

Subscribe to Yahoo Finance Plus Essential for full access

Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level

Source link

About The Author

Scroll to Top